Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 47 Inflammatory Breast Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Obesity 2 Neoplasm Metastasis 2 Central Nervous System Neoplasms 2 Breast Carcinoma In Situ 2 Breast Cancer Female 2 Vitamin D Deficiency 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Sleep Wake Disorders 1 Sexuality 1 Recurrence 1 Pulmonary Fibrosis 1 Nutrition Disorders 1 Neoplasms 1 Melanoma 1 Hormone-receptor-positive Breast Cancer 1 Gliosarcoma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 ER+ Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Breast Cancer Patients in Premenopausal 1 Breast Cancer Organoids 1 Astrocytoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × ER+ Breast Cancer × Tamoxifen × Clear all

NCT05525481 2023-11-01

PREDICTAM

Erasmus Medical Center

Phase 4 Unknown

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡